Lv21
160 积分 2023-08-17 加入
Acidosis orchestrates adaptations of energy metabolism in tumors
1小时前
已完结
Multiscale functional connectivity reveals imbalanced interplay between higher- and lower-order brain networks in ADHD
8天前
已完结
Physiologically based pharmacokinetic modeling of ponatinib to describe drug–drug interactions in patients with cancer
7个月前
已完结
Advancements in physiologically based pharmacokinetic modeling for fedratinib: updating dose guidance in the presence of a dual inhibitor of CYP3A4 and CYP2C19
7个月前
已完结
Prediction of ROS1 and TRKA/B/C occupancy in plasma and cerebrospinal fluid for entrectinib alone and in DDIs using physiologically based pharmacokinetic (PBPK) modeling approach
7个月前
已完结
PBPK Modeling of Entrectinib and Its Active Metabolite to Derive Dose Adjustments in Pediatric Populations Co‐Administered with CYP3A4 Inhibitors
7个月前
已完结
Physiologically Based Pharmacokinetic Modeling of the Drug–Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study
7个月前
已完结
Physiologically based pharmacokinetic modelling to predict drug–drug interactions for encorafenib. Part I. Model building, validation, and prospective predictions with enzyme inhibitors, inducers, and transporter inhibitors
7个月前
已完结
Physiologically based pharmacokinetic modeling (PBPK) to predict drug-drug interactions for encorafenib. Part II. Prospective predictions in hepatic and renal impaired populations with clinical inhibitors and inducers
7个月前
已完结
Application of physiologically based pharmacokinetic modelling for the prediction of drug–drug interactions involving anlotinib as a perpetrator of cytochrome P450 enzymes
7个月前
已完结
皖公网安备34019202002308
